Skip to content
2000
Volume 24, Issue 1
  • ISSN: 2211-3525
  • E-ISSN: 2211-3533

Abstract

Introduction

Urinary tract infections (UTIs) caused by are a significant healthcare concern, particularly in catheterized patients, where biofilm formation enhances bacterial survival and antibiotic resistance. Virulence factors such as the gene, which encodes for adhesin proteins, play a pivotal role in biofilm formation and pathogenicity. This study aims to detect antibiotic resistance patterns, biofilm formation, and gene in isolated from urine samples of catheterized patients.

Methods

from urine cultures was isolated and identified through standard biochemical tests. Biofilm production by uropathogenic isolates was assessed using the microtiter plate method. The antimicrobial susceptibility of the biofilm-producing isolates was determined using the Kirby-Bauer disk diffusion method. Detection of the gene (adhesin) in isolates was conducted using Polymerase Chain Reaction (PCR). The interrelations between biofilm formation, virulence gene presence, and antibiotic resistance in these isolates were analyzed.

Results and Discussion

Out of 49 samples, 36 were found to be biofilm producers. These biofilm producers were categorized into strong, moderate, and weak, with 7 weak, 11 moderate, and 18 strong producers. Among these, the gene was present in 27 isolates. The biofilm-producing exhibited high resistance to ampicillin, ciprofloxacin, and tetracycline.

Conclusion

The gene plays a crucial role in the adherence of biofilm-producing to indwelling catheters, contributing to their resistance to commonly used antibiotics

Loading

Article metrics loading...

/content/journals/aia/10.2174/0122113525375559250509091658
2025-06-02
2026-03-09
Loading full text...

Full text loading...

References

  1. BakerR.E. MahmudA.S. MillerI.F. RajeevM. RasambainarivoF. RiceB.L. TakahashiS. TatemA.J. WagnerC.E. WangL.F. WesolowskiA. MetcalfC.J.E. Infectious disease in an era of global change.Nat. Rev. Microbiol.202220419320510.1038/s41579‑021‑00639‑z 34646006
    [Google Scholar]
  2. MancusoG. MidiriA. GeraceE. MarraM. ZummoS. BiondoC. Urinary tract infections: The current scenario and future prospects.Pathogens202312462310.3390/pathogens12040623 37111509
    [Google Scholar]
  3. BehzadiP. BehzadiE. Uropathogenic Escherichia coli: An ideal resource for DNA microarray probe designing.5th International Work.-Conference on Bioinformatics and Biomedical Engineering (IWBBIO 2017) Spain-Granada, 2017, pp. 12-19.10.1007/978‑3‑319‑56154‑7_2
    [Google Scholar]
  4. JacobsenS.M. SticklerD.J. MobleyH.L.T. ShirtliffM.E. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.Clin. Microbiol. Rev.2008211265910.1128/CMR.00019‑07 18202436
    [Google Scholar]
  5. HootonT.M. Clinical practice. Uncomplicated urinary tract infection.N. Engl. J. Med.2012366111028103710.1056/NEJMcp1104429 22417256
    [Google Scholar]
  6. JiangY. LiJ. ZhangY. HuX. ZhangX. ShangX. GongS. YuR. Clinical situations of bacteriology and prognosis in patients with urosepsis.BioMed Res. Int.201920191308082710.1155/2019/3080827 30881985
    [Google Scholar]
  7. GolpasandT. KeshvariM. BehzadiP. Distribution of chaperone-usher fimbriae and curli fimbriae among uropathogenic Escherichia coli.BMC Microbiol.202424134410.1186/s12866‑024‑03472‑5 39271999
    [Google Scholar]
  8. KranzJ. BartolettiR. BruyèreF. CaiT. GeerlingsS. KövesB. SchubertS. PilatzA. VeeratterapillayR. WagenlehnerF.M.E. BauschK. DevliesW. HorváthJ. LeitnerL. ManticaG. MezeiT. SmithE.J. BonkatG. European association of urology guidelines on urological infections: Summary of the 2024 guidelines.Eur. Urol.2024861274110.1016/j.eururo.2024.03.035
    [Google Scholar]
  9. BehizadiP. UrbánE. MatuzM. BenkőR. GajdácsM. The role of Gram-negative bacteria in urinary tract infections: Current concepts and therapeutic options. Advances in Microbiology, Infectious Diseases and Public Health. DonelliG. ChamSpringer2021Vol. 1323356910.1007/5584_2020_566
    [Google Scholar]
  10. SinghA. TanwarM. SinghT.P. SharmaS. SharmaP. An escape from ESKAPE pathogens: A comprehensive review on current and emerging therapeutics against antibiotic resistance.Int. J. Biol. Macromol.2024279Pt 313525310.1016/j.ijbiomac.2024.135253 39244118
    [Google Scholar]
  11. BehzadiP. García-PerdomoH.A. Autrán GómezA.M. PinheiroM. SarsharM. Editorial: Uropathogens, urinary tract infections, the host-pathogen interactions and treatment.Front. Microbiol.202314118323610.3389/fmicb.2023.1183236 37032879
    [Google Scholar]
  12. FuochiV. FurnariS. TrovatoL. CalvoM. FurneriP.M. Therapies in preclinical and in early clinical development for the treatment of urinary tract infections: From pathogens to therapies.Expert Opin. Investig. Drugs202433767769810.1080/13543784.2024.2351509 38700945
    [Google Scholar]
  13. MirghaniR. SabaT. KhaliqH. MitchellJ. DoL. ChambiL. DiazK. KennedyT. AlkassabK. HuynhT. ElmiM. MartinezJ. SawanS. RijalG. Biofilms: Formation, drug resistance and alternatives to conventional approaches.AIMS Microbiol.20228323927710.3934/microbiol.2022019 36317001
    [Google Scholar]
  14. DerakhshandehS. ShahrokhiN. KhalajV. HabibiM. MoazzezyN. Asadi KaramM.R. BouzariS. Surface display of uropathogenic Escherichia coli fimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.Microb. Pathog.202014110397410.1016/j.micpath.2020.103974 31926238
    [Google Scholar]
  15. SarsharM. BehzadiP. AmbrosiC. ZagagliaC. PalamaraA.T. ScribanoD. FimH and anti-adhesive therapeutics: A disarming strategy against uropathogens.Antibiotics20209739710.3390/antibiotics9070397 32664222
    [Google Scholar]
  16. TchesnokovaV. AprikianP. KisielaD. GoweyS. KorotkovaN. ThomasW. SokurenkoE. Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli.Infect. Immun.201179103895390410.1128/IAI.05169‑11 21768279
    [Google Scholar]
  17. BehzadiP. KimC.H. PawlakE.A. AlgammalA. Editorial: The innate and adaptive immune system in human urinary system.Front. Immunol.202314129486910.3389/fimmu.2023.1294869 37876936
    [Google Scholar]
  18. HojatiZ. MolaieR. GholipourA. MolaieR. GholipourA. The FimH gene in uropathogenic Escherichia coli strains isolated from patients with urinary tract infection.Jundishapur J. Microbiol.201582e1752010.5812/jjm.17520 25825648
    [Google Scholar]
  19. KhonsariM.S. BehzadiP. ForoohiF. The prevalence of type 3 fimbriae in uropathogenic Escherichia coli isolated from clinical urine samples.Meta Gene20212810088110.1016/j.mgene.2021.100881
    [Google Scholar]
  20. ZhaoF. YangH. BiD. KhalediA. QiaoM. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.Microb. Pathog.202014410419610.1016/j.micpath.2020.104196 32283258
    [Google Scholar]
  21. WerneburgG.T. Catheter-associated urinary tract infections: Current challenges and future prospects.Res. Rep. Urol.20221410913310.2147/RRU.S273663 35402319
    [Google Scholar]
  22. RajangamS.L. LeelaK.V. JayaramanM. SabarathinamS. NarasimhanM.K. Effect of amikacin-humic acid combination on Acinetobacter baumannii biofilm: An in vitro and in silico study.Future Microbiol.202419181573158510.1080/17460913.2024.2412431 39429208
    [Google Scholar]
  23. HudzickiJ. Kirby-bauer disk diffusion susceptibility test protocol.American Society for Microbiology2009151123 https://asm.org/getattachment/2594ce26-bd44-47f6-8287-0657aa9185ad/kirby-bauer-disk-diffusion-susceptibility-test-protocol-pdf.pdf
    [Google Scholar]
  24. MagiorakosA.P. SrinivasanA. CareyR.B. CarmeliY. FalagasM.E. GiskeC.G. HarbarthS. HindlerJ.F. KahlmeterG. Olsson-LiljequistB. PatersonD.L. RiceL.B. StellingJ. StruelensM.J. VatopoulosA. WeberJ.T. MonnetD.L. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance.Clin. Microbiol. Infect.201218326828110.1111/j.1469‑0691.2011.03570.x 21793988
    [Google Scholar]
  25. RubioM.S. Penha FilhoR.A.C. AlmeidaA.M. BerchieriA. Development of a multiplex qPCR in real time for quantification and differential diagnosis of Salmonella Gallinarum and Salmonella] Pullorum.Avian Pathol.201746664465110.1080/03079457.2017.1339866 28589774
    [Google Scholar]
  26. KatongoleP. NalubegaF. FlorenceN.C. AsiimweB. AndiaI. Biofilm formation, antimicrobial susceptibility and virulence genes of uropathogenic Escherichia coli isolated from clinical isolates in Uganda.BMC Infect. Dis.202020145310.1186/s12879‑020‑05186‑1 32600258
    [Google Scholar]
  27. AlshaikhS.A. El-bannaT. SonbolF. FarghaliM.H. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital.Ann. Clin. Microbiol. Antimicrob.20242312010.1186/s12941‑024‑00679‑2 38402146
    [Google Scholar]
  28. HoláV. Opazo-CapurroA. ScavoneP. Editorial: The biofilm lifestyle of uropathogens.Front. Cell. Infect. Microbiol.20211176341510.3389/fcimb.2021.763415 34604120
    [Google Scholar]
/content/journals/aia/10.2174/0122113525375559250509091658
Loading
/content/journals/aia/10.2174/0122113525375559250509091658
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test